Synairgen (SNG.L): Completion of recruitment of hospitalised patients in Covid-19 Trial | Oncimmune Holdings (ONC.L): Contract Signed with Roche | N4 Pharma (N4P.L): Covid-19 Project Update
28 May 2020
SP Angel Healthcare Conditions
Synairgen plc (SNG:LON), 4.8 | Oncimmune Holdings Plc (ONC:LON), 21.2 | N4 Pharma Plc (N4P:LON), 0.6
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
Synairgen plc (SNG:LON), 4.8 | Oncimmune Holdings Plc (ONC:LON), 21.2 | N4 Pharma Plc (N4P:LON), 0.6
- Published:
28 May 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
Synairgen (SNG.L): Completion of recruitment of hospitalised patients in Covid-19 Trial | Oncimmune Holdings (ONC.L): Contract Signed with Roche | N4 Pharma (N4P.L): Covid-19 Project Update